GSK, Pfizer Plans To Combine HIV Drugs Business

by VR Sreeraman on  April 17, 2009 at 12:21 PM Corporate News
RSS Email Print This Page Comment
Font : A-A+

GlaxoSmithKline and Pfizer, two of the world's largest pharmaceutical groups, are planning to combine their HIV drugs businesses into a new company, GSK said Thursday.
 GSK, Pfizer Plans To Combine HIV Drugs Business
GSK, Pfizer Plans To Combine HIV Drugs Business

The new combined company will sell 11 existing drugs produced by the two firms, holding a 19 percent share of the market and generating annual sales of about 1.6 billion pounds (1.8 billion euros, 2.4 billion dollars), Britain-based GSK said.

Initially controlled 85 percent by GSK and 15 percent by Pfizer, it will also focus on research and development of new HIV treatments and formulations, including developing six new drugs already in the pipeline.

"We are creating a new global leader in HIV and reaffirming our ongoing commitment to the treatment of the disease," said Pfizer chief Jeff Kindler.

GSK chief executive Andrew Witty said the agreement marked a "definitive step" to deliver more medicines, more efficiently.

"At the core of this specialist business is a broad portfolio of products and pipeline assets, which can be more effectively leveraged through the new company's strong revenue base and dedicated research capability," he said.

"HIV remains a global threat with increasing incidence and viral resistance. This new company will be better placed to meet these challenges and improve access to treatments."

Source: AFP
SRM

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Oral Health And AIDS Drug Toxicity AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs Signature Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive